Celltrion, “Biogen’s confirmation trials are only a part of procedures for the Patent Linkage System”
When it comes to the 3 active confirmation trials for the scope of the right, which was filed by Biogen over CT-P10(product name: Truxima) against Celltrion, Celltrion expressed opinions.
On the 15th, Celltrion stated the confirmation trials filed by the original company, Biogen, on the 4th of F...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
